[Federal Register Volume 66, Number 188 (Thursday, September 27, 2001)]
[Notices]
[Page 49431]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-24178]


=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Issuer Delisting; Notice of Application to Withdraw from Listing 
and Registration on the Pacific Exchange, Inc. (Pharmaceutical 
Resources, Inc., Common Stock, of $.01 Par Value, and Common Stock 
Purchase Rights) File No. 1-10827

September 24, 2001.
    Pharmaceutical Resources, Inc., a New Jersey corporation 
(``Issuer''), has filed an application with the Securities and Exchange 
Commission (``Commission''), pursuant to Section 12(d) of the 
Securities Exchange Act of 1934 (``Act'') \1\ and Rule 12d2-2(d) 
thereunder,\2\ to withdraw its Common Stock, $.01 par value, and Common 
Stock Purchase Rights (``Securities'') from listing and registration on 
the Pacific Exchange, Inc. (``PCX'').
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 781(d).
    \2\ 17 CFR 240.12d2-2(d).
---------------------------------------------------------------------------

    The Board of Directors (``Board'') of the Issuer approved a 
resolution on July 9, 2001 to withdraw its Securities from listing on 
the Exchange. The Board believes that it is in its best interest to 
reduce its listing expenses and corporate oversight by limiting the 
number of exchanges on which the securities are listed. The Issuer will 
continue to list its Common Stock on the New York Stock Exchange, Inc. 
(``NYSE'').
    The Issuer states in its application that it has met the 
requirements of the PCX by complying with all applicable laws in effect 
in the state of New Jersey, in which it is incorporated, and with the 
PCX's rules governing an issuer's voluntary withdrawal of a security 
from listing and registration. The Issuer's application related solely 
to the withdrawal of the Securities from the PCX and shall have no 
affect upon its listing on the NYSE or its registration under Section 
12(b) of the Act.\3\
---------------------------------------------------------------------------

    \3\ 15 U.S.C. 781(b).
---------------------------------------------------------------------------

    Any interested person may, on or before October 12, 2001, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, NW., Washington, DC 20549-0609, facts bearing upon 
whether the application has been made in accordance with the rules of 
the PCX and what terms, if any, should be imposed by the Commission for 
the protection of investors. The Commission, based on the information 
submitted to it, will issue an order granting the application after the 
date mentioned above, unless the Commission determines to order a 
hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.\4\
---------------------------------------------------------------------------

    \4\ 17 CFR 200.30-3(a)(1).
---------------------------------------------------------------------------

Jonathan G. Katz,
Secretary.
[FR Doc. 01-24178 Filed 9-26-01; 8:45 am]
BILLING CODE 8010-01-M